Lixte Biotechnology Holdings, Inc.
LIXT
$5.16
$0.122.38%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 76.84% | 225.51% | -35.93% | 33.27% | -36.55% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -21.69% | -10.93% | -20.85% | 21.48% | 107.80% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -4.70% | 448.97% | -34.63% | 32.19% | -32.18% |
|
|
|||||
| Total Current Assets | -4.70% | 448.97% | -34.63% | 32.19% | -32.18% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 134.34% | 357.15% | -21.50% | 32.19% | -32.45% |
|
|
|||||
| Total Accounts Payable | 150.61% | 50.91% | -27.02% | 101.97% | -23.59% |
| Total Accrued Expenses | 12.50% | 1,020.00% | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 5.50% | -35.84% | 83.43% | 3.19% | -8.20% |
| Total Other Current Liabilities | 5.50% | -35.84% | 83.43% | 3.19% | -8.20% |
| Total Current Liabilities | 155.68% | -2.92% | 51.25% | 11.56% | -3.25% |
|
|
|||||
| Total Current Liabilities | 155.68% | -2.92% | 51.25% | 11.56% | -3.25% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 239.87% | -2.92% | 51.25% | 11.56% | -3.25% |
|
|
|||||
| Common Stock & APIC | 14.02% | 6.80% | 7.47% | 2.11% | 0.16% |
| Retained Earnings | -4.58% | -3.70% | -1.47% | -1.36% | -1.20% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 236.28% | 262.07% | 127.83% | 12.42% | -25.30% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -32.18% | -- | -- | 0.00% | 0.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -32.18% | -- | -- | 0.00% | 0.00% |
|
|
|||||
| Total Common Equity | 236.28% | 262.07% | 127.83% | 12.42% | -25.30% |
| Total Preferred Equity | -32.18% | -- | -- | 0.00% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 123.15% | 654.00% | -43.79% | 40.12% | -39.48% |
|
|
|||||